Reassessing Immunotherapy Use in Advanced Renal Cell Carcinoma
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.
There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were treated in the advanced setting.
Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to immune checkpoint inhibitors.
Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.
Heather Patenaude, B.S.N., RN, displays the highest level of technical skills necessary to provide compassionate care to her patients.
Dr. Andrew M. Evens discusses some of the recent research advancements in AYA lymphoma care that have emerged through clinical trials and initiatives.
After my breast cancer treatment, I started a clothing bank to give others free access to recovery items like post-surgery shirts and pillows.
WASHINGTON, D.C., May 23, 2025 – The American Association of Colleges of Nursing (AACN) applauds the introduction of the Title VIII Nursing Workforce Reauthorization Act…
I urge researchers to look into why side effects occur in cancer drugs and to find ways to mitigate them that doesn’t impact their efficacy.
Read about the founder of a nurse campaign group who said she would be willing to go on strike over the 2025-26 nurse pay deal.
Read about why nurse Sandie Peggie has called on her union to intervene in her case against NHS Fife related to single-sex changing rooms.
Read about why nurse Sandie Peggie has called on her union to intervene in her case against NHS Fife related to single-sex changing rooms.